Tuberculosis News and Research

Latest Tuberculosis News and Research

Neisseria species are linked to worsening bronchiectasis in patients, study shows

A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered that Neisseria - a genus of bacteria that lives in the human body - is not as harmless as previously thought, and can cause infections in patients with bronchiectasis, asthma, and chronic obstructive pulmonary disease (COPD).

14 Sep 2022

AI system can quickly and automatically evaluate chest X-rays for TB

An artificial intelligence system detects tuberculosis (TB) in chest X-rays at a level comparable to radiologists, according to a study published in Radiology, a journal of the Radiological Society of North America.

13 Sep 2022

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.

13 Sep 2022

The impact of the infant gut microbiome on vaccine efficacy

A new study reports the effect of the infant gut microbiome on vaccine efficacy.

13 Sep 2022

Update on SARS-CoV-2 variants detected in animals by USDA

The USDA APHIS has recently updated its web-based dashboard to provide information on all SARS-CoV-2 variants detected in animals

12 Sep 2022

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them.

9 Sep 2022

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

9 Sep 2022

Booster vaccination maintains high efficacy against malaria in African children

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ - which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.

9 Sep 2022

Leopoldina Annual Assembly focuses on broad spectrum of global health issues

The aim of global health is to improve the situation of and equity for the entire global population with respect to health.

6 Sep 2022

Tattoos can induce bloodstream infections

A recent review describes the characteristics of systemic bacterial infections associated with tattoos.

28 Aug 2022

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

In new research, researchers extensively searched for the origins of the resistance to recognizing airborne transmission during the coronavirus disease 2019 (COVID-19) pandemic by major public health organizations, including the World Health Organization (WHO) and the United States Centers of Disease Control and Prevention (US-CDC).

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

A recent study examines the potential effects of tobacco use on COVID-19.

21 Aug 2022

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

Two days after arriving at a temporary migrant shelter at the border with the U.S. in June, Rosa Viridiana Ceron Alpizar's 9-year-old daughter and 1-year-old son fell ill. Most of the kids in the converted gym had stomach issues after being served a meal of sausage and beans, she recalled.

17 Aug 2022

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.

17 Aug 2022

Next-generation sequencing system yields results comparable to traditional diagnostics

In the pursuit of accurate diagnoses for illnesses, doctors have traditionally used multiple methods — including culturing patient samples on a wide variety of media, reviewing countless medical records and analyzing clinical data using complex mathematical algorithms — to try to identify the bacterium, virus, fungus or other pathogen responsible for an infection.

10 Aug 2022

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments.

8 Aug 2022

BCG vaccine produces a "trained immunity response" which lasts more than a year

The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.

8 Aug 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

Neisseria species are linked to worsening bronchiectasis in patients, study shows

AI system can quickly and automatically evaluate chest X-rays for TB

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

The impact of the infant gut microbiome on vaccine efficacy

Update on SARS-CoV-2 variants detected in animals by USDA

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

Weill Cornell Medicine receives $5 million NIH grant for next generation TB research

Booster vaccination maintains high efficacy against malaria in African children

Leopoldina Annual Assembly focuses on broad spectrum of global health issues

Tattoos can induce bloodstream infections

Resistance to recognizing airborne transmission of SARS-CoV-2 may be rooted in historical error

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Modified TB vaccine could help treat non-muscle invasive bladder cancer

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

Shelter sickness: Migrants see health problems linger and worsen while waiting at the border

The BCG vaccine against COVID-19 and other infectious diseases in type 1 diabetic adults

Next-generation sequencing system yields results comparable to traditional diagnostics

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

BCG vaccine produces a "trained immunity response" which lasts more than a year

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in